Technology News and Research

RSS

National Jewish Health issued method patent for desensitizing B cells

National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department of Immunology at National Jewish Health, holds promise for treatment of B-cell mediated diseases, such as lymphoma and leukemia, rheumatoid arthritis, lupus and rejection of organ transplants.

19 Jan 2011

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Point of Care Solutions introduces its Agile Medical Platform, the latest integrated practice management and ambulatory Electronic Health Record system available in the United States to manage physician medical practices with a ubiquitous interface.

19 Jan 2011

Study demonstrates clinical accuracy of Masimo's noninvasive, continuous hemoglobin monitoring technology

Masimo announced today that a new clinical study demonstrating the clinical accuracy of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented last week at the Society for Technology in Anesthesia (STA) Annual Meeting.

19 Jan 2011

New study provides clear data on high rate of childhood maltreatment among deaf community

A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.

19 Jan 2011

Almac reports substantial progress in transitioning operations to new headquarters

Almac is making substantial progress in transitioning operations to its new headquarters in Souderton, PA, especially in the area of distribution. The new facility has been successfully shipping clinical trial materials since November, and has recently seen an increase in shipment volumes due to the added efficiencies the new building provides.

19 Jan 2011

New patented technique offers unprecedented view of DNA damage

New technology providing the first view of DNA damage throughout the entire human genome developed by Cardiff University scientists could offer a valuable new insight into the development and treatment of conditions like cancer.

19 Jan 2011

UAB study uses InQ system to evaluate effects of secondary injury components on brain cells

InQ Biosciences, a provider of innovative technologies for cell growth and research, today announced that a pre-commercial version of its InQ Cell Research System is being utilized in a University of Alabama at Birmingham study evaluating the effects of secondary injury components on brain cells.

19 Jan 2011

New GORE VIABAHN Endoprosthesis is now available in Europe

W. L. Gore & Associates today announced the European availability of the GORE VIABAHN Endoprosthesis on a lower profile delivery system. The announcement came during the Leipzig Interventional Course in Germany, where European interventionalists gathered to discuss new approaches in treating patients suffering from peripheral artery disease.

19 Jan 2011

Arrowhead increases ownership in Calando's outstanding equity to 79%

Arrowhead Research Corporation today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted approximately $8M of Calando debt to Arrowhead into equity. Arrowhead now owns approximately 79% of Calando's outstanding equity.

19 Jan 2011

Neuroform EZ Stent System helps neurosurgeons to treat brain aneurysms

A new device to treat brain aneurysms with stents improves access to the blood vessels allowing endovascular neurosurgeons to offer the minimally invasive technique to patients with complex cases. Dr. Demetrius Lopes, an endovascular neurosurgeon at Rush University Medical Center, was the first in the U.S. to use the new delivery system, called the Neuroform EZ Stent System.

19 Jan 2011

Cancer cells brought back under normal control

Scientists at The University of Nottingham have brought cancer cells back under normal control — by reactivating their cancer suppressor genes. The discovery could form a powerful new technology platform for the treatment of cancer of the breast and other cancers.

19 Jan 2011

Aastrom secures US patent for autologous cell therapy product

Aastrom Biosciences, a leading developer of expanded autologous cellular therapies for severe, chronic cardiovascular diseases, today announced that it has been granted a U.S. patent which provides composition of matter protection for its investigational expanded autologous cell therapy product.

19 Jan 2011

First successful transcatheter implantation of 27mm transapical aortic valve prosthesis

JenaValve™ Technology, Inc., a medical device company specializing in developing transcatheter aortic valve implantation (TAVI) systems, announced today a significant clinical milestone: the first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis.

19 Jan 2011

Concordia study finds younger adults react faster to sudden changes

Does experience give seniors an edge in reacting to sudden change or are younger people quicker to respond? A new study from Concordia University shows that when a routine task is interrupted by an unexpected event, younger adults are faster at responding.

19 Jan 2011

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

With an invention that can be made from some of the same parts used in CD players, University of Michigan researchers have developed a way to measure the growth and drug susceptibility of individual bacterial cells without the use of a microscope.

19 Jan 2011

Celulas Genetica, EHRI enter joint venture to pursue testing of Rutherford Procedure using NASA bioreactor

Emerging Healthcare Solutions, announced today that it has entered into a joint venture agreement with its wholly owned subsidiary, Celulas Genetica, in order to pursue testing of the revolutionary Rutherford Procedure using a NASA bioreactor.

19 Jan 2011

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.

18 Jan 2011

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

Clinipace Worldwide achieves over 800% revenue growth since 2008

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that it recently closed its best year to date, achieving over 800% revenue growth since 2008. The company more than doubled its revenues in 2010 over the prior year, attributable to 16 new projects awarded from 12 new clients.

18 Jan 2011

Brush Engineered Materials to become Materion Corporation

Brush Engineered Materials Inc. today announced it will change its name to Materion Corporation and unify all of its businesses under the new name effective March 8, 2011. The Company's common stock will continue to trade on the New York Stock Exchange.

18 Jan 2011

Technology News and Research

National Jewish Health issued method patent for desensitizing B cells

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Study demonstrates clinical accuracy of Masimo's noninvasive, continuous hemoglobin monitoring technology

New study provides clear data on high rate of childhood maltreatment among deaf community

Almac reports substantial progress in transitioning operations to new headquarters

New patented technique offers unprecedented view of DNA damage

UAB study uses InQ system to evaluate effects of secondary injury components on brain cells

New GORE VIABAHN Endoprosthesis is now available in Europe

Arrowhead increases ownership in Calando's outstanding equity to 79%

Neuroform EZ Stent System helps neurosurgeons to treat brain aneurysms

Cancer cells brought back under normal control

Aastrom secures US patent for autologous cell therapy product

First successful transcatheter implantation of 27mm transapical aortic valve prosthesis

Concordia study finds younger adults react faster to sudden changes

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

Celulas Genetica, EHRI enter joint venture to pursue testing of Rutherford Procedure using NASA bioreactor

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

Clinipace Worldwide achieves over 800% revenue growth since 2008

Brush Engineered Materials to become Materion Corporation

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News